Car Sales Still Spe...
Health Care: Drugs
Avigen Inc. (AVGN: NASDAQ)
$1.32 0.00 | 0.00%
12/18/09 - 04:00 PM ET
TheStreet Ratings Grade for AVGN
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 3.00 | 3.00 | 3.00 | 3.00 |
Portfolios with AVGN
- Portfolio NameUser Type
- UserCatalyst Investment Research
- UserBVF Inc.
- UserMangar's picks
- Userritaomg
- Usermilindks Portfolio 1
- UserSUPRATRADE 2606071340
- UserAShah Biotech Portfolio
- Userstockjock Portfolio 1
- UserCulann Smith Portfolio 1
- UserMore portfolio
Latest AVGN Headlines from TheStreet
- Director David Abrams Sells $19.7M Worth of Crown Castle 12.17.09 | 09:12 am
- After Long Courtship, MediciNova To Buy Avigen 08.21.09 | 09:08 am
- Latest Activist Situations 01.09.09 | 11:01 am
- Activist Stocks for the Week 12.17.08 | 11:12 am
- Genzyme's Gene Therapy Grows 12.21.05 | 01:12 pm
Press Releases for AVGN
Partner Headlines for AVGN
